The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
EP2493478
WO Application Number:
CA2010001720
Type:
European Patent Granted for NL
Status:
Lapsed by non-payment of annual fee Art. 62 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP10825905.2
WO Publication Number:
WO2011050474
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Canada (CA)
Publications:
Dates
Filing date:
29/10/2010
Grant date:
21/02/2018
EP Publication Date:
05/09/2012
WO Publication Date:
05/05/2011
Claims Translations Received Date:
Claims Translation B1 Received Date:
23/03/2018
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
01/11/2023
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
21/02/2018
EP B1 Publication Date:
21/02/2018
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
28/10/2030
Lapsed By Expiration Date:
Patent Validated Date:
07/04/2018
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
06/04/2018
Name:
Acasti Pharma, Inc.
Address:
545 Promenade du Centropolis, Suite 100, H7T 0A3, Laval, Quebec H7, Canada (CA)
Agent
Name:
J.M.H. Duyver lic.
From:
06/04/2018
Address:
Gevers Patents
De Kleetlaan 7A, B-1831, Diegem, Belgium (BE)